Applicant, as named in the Orange Book

Intrabio

Next listed expiry: Aqneursa on 19 Apr 2037. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Aqneursa levacetylleucine	levacetylleucine	219132	19 Apr 2037	patent, carve-out possible

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.